Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Jain

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Chest|November 5, 2014
Fibroproliferative ARDS in the Era of low-tidal-volume ventilationManu Jain
Translational Research : the Journal of Laboratory and Clinical Medicine|January 1, 2013
Gene therapy in cystic fibrosisMichelle Prickett, Manu Jain
Expert Opinion on Pharmacotherapy|July 25, 2006
Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcersManu Jain, John Varga
JAMA|October 28, 2004
Emphysematous cystitis and renal stones in cystic fibrosisDaya Upadhyay, Manu Jain
American Journal of Respiratory and Critical Care Medicine|December 20, 2012
Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosisMichelle Prickett, Manu Jain
Proceedings of the American Thoracic Society|October 14, 2005
Effects of hypoxia on the alveolar epitheliumManu Jain, Jacob Iasha Sznajder
Current Opinion in Critical Care|January 16, 2008
Peripheral airways injury in acute lung injury/acute respiratory distress syndromeManu Jain, J Iasha Sznajder
American Journal of Respiratory and Critical Care Medicine|April 17, 2014
Reply: antioxidants in the intensive care unitManu Jain, Navdeep S Chandel
American Journal of Respiratory and Critical Care Medicine|June 23, 2012
Personalized medicine in cystic fibrosis: dawning of a new eraJohn P Clancy, Manu Jain
American Journal of Respiratory and Critical Care Medicine|October 23, 2019
Combination Therapy with Lumacaftor-Ivacaftor in Cystic Fibrosis. Keeping It RealMarc A Sala, Manu Jain
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Chest|November 5, 2014
Fibroproliferative ARDS in the Era of low-tidal-volume ventilationManu Jain
Translational Research : the Journal of Laboratory and Clinical Medicine|January 1, 2013
Gene therapy in cystic fibrosisMichelle Prickett, Manu Jain
Expert Opinion on Pharmacotherapy|July 25, 2006
Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcersManu Jain, John Varga
JAMA|October 28, 2004
Emphysematous cystitis and renal stones in cystic fibrosisDaya Upadhyay, Manu Jain
American Journal of Respiratory and Critical Care Medicine|December 20, 2012
Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosisMichelle Prickett, Manu Jain
Proceedings of the American Thoracic Society|October 14, 2005
Effects of hypoxia on the alveolar epitheliumManu Jain, Jacob Iasha Sznajder
Current Opinion in Critical Care|January 16, 2008
Peripheral airways injury in acute lung injury/acute respiratory distress syndromeManu Jain, J Iasha Sznajder
American Journal of Respiratory and Critical Care Medicine|April 17, 2014
Reply: antioxidants in the intensive care unitManu Jain, Navdeep S Chandel
American Journal of Respiratory and Critical Care Medicine|June 23, 2012
Personalized medicine in cystic fibrosis: dawning of a new eraJohn P Clancy, Manu Jain
American Journal of Respiratory and Critical Care Medicine|October 23, 2019
Combination Therapy with Lumacaftor-Ivacaftor in Cystic Fibrosis. Keeping It RealMarc A Sala, Manu Jain
Pageof 16